The median increase in the potassium level from baseline of that phase was greater with placebo than with patiromer ( P < @ ) ; a recurrence of hyperkalemia ( potassium level , @ mmol per liter ) occurred in @ % of the patients in the placebo group as compared with @ % in the patiromer group through week @ ( P < @ ) .